Literature DB >> 22238206

Transfusion medicine problems and solutions for the pediatric hematologist/oncologist.

Naomi L C Luban1, Eileen McBride, Jason C Ford, Sumit Gupta.   

Abstract

Blood component transfusion is an integral part of the care of children with oncologic and hematologic conditions. The complexity of transfusion medicine may however lead to challenges for pediatric hematologists/oncologists. In this review, three commonly encountered areas of transfusion medicine are explored. The approach to the investigation and management of suspected platelet refractoriness is reviewed. The unique transfusion related challenges encountered by children undergoing stem cell transplantation are also discussed. Finally, issues arising out of the care of children with hemoglobinopathies are explored, with an emphasis on the incidence of allo- and autoimmunization.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22238206      PMCID： PMC3328596          DOI： 10.1002/pbc.24077

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


  53 in total

1.  A pilot study to assess physician knowledge in transfusion medicine.

Authors:  G Rock; R Berger; P Pinkerton; B Fernandes
Journal:  Transfus Med       Date:  2002-04       Impact factor: 2.019

2.  Management of patients refractory to platelet transfusion.

Authors:  Ronald A Sacher; Thomas S Kickler; Charles A Schiffer; Laurence A Sherman; Arthur W Bracey; Ira A Shulman
Journal:  Arch Pathol Lab Med       Date:  2003-04       Impact factor: 5.534

Review 3.  The effectiveness of interventions to reduce physician's levels of inappropriate transfusion: what can be learned from a systematic review of the literature.

Authors:  Kumanan Wilson; Laura MacDougall; Dean Fergusson; Ian Graham; Alan Tinmouth; Paul C Hébert
Journal:  Transfusion       Date:  2002-09       Impact factor: 3.157

4.  Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial.

Authors:  E P Vichinsky; N L Luban; E Wright; N Olivieri; C Driscoll; C H Pegelow; R J Adams
Journal:  Transfusion       Date:  2001-09       Impact factor: 3.157

5.  Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation.

Authors:  J Maciej Zaucha; Marco Mielcarek; Alessandra Takatu; Marie-Terese Little; Theodore Gooley; Jennifer Baker; David G Maloney; Brenda M Sandmaier; Michael Maris; Thomas Chauncey; Rainer Storb; Beverly Torok-Storb
Journal:  Br J Haematol       Date:  2002-12       Impact factor: 6.998

6.  Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning.

Authors:  Nina Worel; Hildegard T Greinix; Felix Keil; Margit Mitterbauer; Klaus Lechner; Gottfried Fischer; Wolfgang Mayr; Paul Höcker; Peter Kalhs
Journal:  Transfusion       Date:  2002-10       Impact factor: 3.157

7.  Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME).

Authors:  Michele Lasalle-Williams; Rachelle Nuss; Tuan Le; Laura Cole; Kathy Hassell; James R Murphy; Daniel R Ambruso
Journal:  Transfusion       Date:  2011-02-18       Impact factor: 3.157

Review 8.  Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.

Authors:  Banu Aygun; Savitri Padmanabhan; Carole Paley; Visalam Chandrasekaran
Journal:  Transfusion       Date:  2002-01       Impact factor: 3.157

9.  Posttransplant immune-mediated hemolysis.

Authors:  Robert J Sokol; Robert Stamps; David J Booker; Fiona M Scott; Stuart T Laidlaw; Elisabeth A Vandenberghe; Helen F Barker
Journal:  Transfusion       Date:  2002-02       Impact factor: 3.157

Review 10.  CMV and blood transfusions.

Authors:  John D Roback
Journal:  Rev Med Virol       Date:  2002 Jul-Aug       Impact factor: 6.989
View more
  2 in total

1.  Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME).

Authors:  Elliott Vichinsky; Lynne Neumayr; Sean Trimble; Patricia J Giardina; Alan R Cohen; Thomas Coates; Jeanne Boudreaux; Ellis J Neufeld; Kristy Kenney; Althea Grant; Alexis A Thompson
Journal:  Transfusion       Date:  2013-07-25       Impact factor: 3.157

2.  A novel strategy for the screening for platelet refractoriness: prospects and limitations.

Authors:  Valder R Arruda
Journal:  Rev Bras Hematol Hemoter       Date:  2013
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.